Will Worden has represented startups, early stage, and public and private companies in connection with intellectual property and transactional matters for almost 20 years. Will was one of the pioneering attorneys on transactions involving animal cloning technologies and the commercialization of regenerative medicine technologies, including stem cell technologies. His clients include companies and institutions in a variety of technology industries, including life science and biotechnology, manufacturing, semiconductors, software, and information technology. Will is also the partner-in-charge of the firm's Boston office and Chair of the firm's Intellectual Property & Technology Practice Group.
Will brings real-world experience to bear on the legal issues facing firm clients, using his background in agriculture, animal science, and IP to help identify and protect their intellectual property and to determine the best path to commercialization.
Will is partner-in-charge of Pierce Atwood's Boston office.